Easy bruising resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sanjana Nethagani, M.B.B.S.[2]
Overview
Easy bruising is the bruising of skin with minor compression or pressure. When small capillaries of the superficial skin rupture from pressure or compression, petechiae occur, sometimes ecchymosis is also seen with insignificant trauma which is a bleed in the deeper layers in the skin[1]. A wide variety of causes lead to easy bruising, some of which are clotting and bleeding disorders, platelet dysfunction, age related skin changes, and some forms of cancer such as leukemia.[2]
Causes
Life threatening causes
- Thrombotic Thrombocytopenic Purpura
- Disseminated intravascular coagulation
- Leukemia
- Severe thrombocytopenia
Other causes
- Hemophilia A
- Hemophilia B
- Scurvy
- Von Willebrand disease
- Ehlers-Danlos syndrome
- Corticosteroid use
- Anticoagulant therapy
- Idiopathic Thrombocytopenic Purpura
- Henoch-Schonlein Purpura
- Vitamin K deficiency
- Liver disease
- Systemic Lupus Erythematosus
- Glanzmann Thrombasthenia
- Bernard-Soulier syndrome
For a full list of causes of easy bruising, click here.
Diagnosis
The algorithm below summarises approach to the different causes of easy bruising.[3][4]
Detailed history: ❑ Is the bleeding over the limbs? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characterize the symptoms ❑ Bruising with minor or no trauma ❑ Petechiae ❑ Gingival bleeding ❑ Menorrhagia ❑ Painful bleeding into joints | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial investigations ❑ Complete blood count with platelet count ❑ PT/aPTT ❑ INR ❑ Liver function tests ❑ Thyroid function tests ❑ Renal function tests ❑ Peripheral smear ❑ Bleeding time ❑ Platelet function analyzer Other investigations ❑ Factor VIII level ❑ Factor IX level ❑ Fibrinogen level ❑ ADAMTS13 level | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disorders of secondary hemostasis ❑ Abnormal PT/aPTT ❑ Abnormal factor assays ❑ Abnormal fibrinogen level | Decreased platelet count ❑ mild: 100,000 - 150,000 per µL ❑ moderate: 50,000 to 99,000 per µL ❑ severe: <50,000 per µL (may require transfusion) | Disorders of platelet function ❑ Prolonged bleeding time ❑ Thrombocytopenia ❑ Abnormal PFA-100 ❑ Abnormal Von Willebrand factor assay ❑ Abnormal Ristocetin induced platelet agglutination | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clotting factor disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inherited | Acquired | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Von Willebrand disease * Abnormal Von Willebrand factor assay * Abnormal Glycoprotein 1b assay * Hypoactive agglutination on ristocetin induced platelet aggregation * Low factor VIII levels * Prolonged PTT ❑ Glanzmann's thrombasthenia * Abnormal platelet aggregation assays * Monoclonal antibody testing * Flow cytometry ❑ Bernard-Soulier syndrome * Giant platelets on peripheral smear * Abnormal ristocetin aggregation ❑ Oculocutaneous albinism/Hermansky-Pudlak syndrome * Absent dense bodies on electron microscopy of platelets * Abnormal platelet aggregation assays ❑ Chédiak-Higashi syndrome * Abnormal platelet aggregation assays * Defective platelet storage granules ❑ Isolated dense granule deficiency * Defective platelet aggregation * Decreased ADP/ATP ratio | ❑ Uremia ❑ Acquired Von Willebrand disease ❑ Aspirin and other NSAIDs ❑ Glycoprotein IIb/IIIa inhibitors ❑ Cardiopulmonary bypass ❑ Dysproteinemia ❑ Myeloproliferative disorders ❑ Cardiopulmonary bypass ❑ Infections such as Dengue fever or Hepatitis C | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No abnormalities detected in initial analysis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Consider other diagnoses ❑ Senile purpura ❑ Aplastic anemia ❑ Long term corticosteroid use ❑ Scurvy ❑ Vitamin K deficiency ❑ Domestic abuse ❑ Leukemia ❑ Meningococcal infection ❑ Ehlers-Danlos syndrome ❑ Alpha 2-antiplasmin deficiency ❑ Plasminogen activator inhibitor-1 deficiency ❑ Factor XIII deficiency ❑ Lupus anticoagulant ❑ Antiphospholipid syndrome ❑ ITP ❑ TTP/HUS ❑ Liver disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic clues
Shown below is a table summarizing different findings in easy bruising and their interpretation.
Platelet count | Bleeding time | RIPA | Peripheral smear | PT | aPTT | Fibrinogen | Thrombin time | Factor assays | Associated conditions |
---|---|---|---|---|---|---|---|---|---|
↓ | ↑ | Normal | Few platelets on smear | Normal | Normal | Normal | Normal | Normal | Thrombocytopenia |
Normal | ↑ | Hypoactive agglutination | Normal | Normal | Normal/ slightly prolonged | Normal | Normal | ↓ Factor VIII | Von Willebrand disease |
↓ | ↑ | Hypoactive agglutination & normal ristocetin cofactor assay | Giant platelets | Normal | Normal | Normal | Normal | Normal | Bernard-Soulier syndrome |
Normal | ↑ | Clumping with ristocetin | Normal | Normal | Normal | Normal | Normal | Normal | Glanzmann's thrombasthenia |
Normal | Normal | Normal | Normal | Normal | ↑ | Normal | Normal | ↓ Factor VIII, IX, XI or XII | Hemophilia A, Hemophilia B, use of Heparin, Antiphospholipid syndrome or Lupus anticoagulant |
Normal | Normal | Normal | Normal | ↑ | Normal | Normal | Normal | ↓ Factor VII | Factor VII deficiency, early in the course of treatment with warfarin, initial stages of liver disease |
Normal | Normal | Normal | Normal | ↑ | ↑ | Normal | Normal | ↓ Factor II, V & X | Factor II, V or X deficiency, oral anticoagulant use, Vitamin K deficiency, chronic liver disease |
Normal | Normal | Normal | Normal | ↑ | ↑ | Normal | ↑ | Normal | Chronic liver disease, hyperfibrinolysis, heparin use |
Normal/↓ | ↓ | Normal | Normal | Normal | Normal | Normal | Normal | Normal | Splenomegaly, chemotherapy, immune mediated destruction |
↓ | ↑ | Normal | Normal | ↑ | ↑ | ↓ | ↑ | Normal | Multiple transfusions, massive blood loss |
↓ | ↑ | Normal | Shistocytes | ↑ | ↑ | ↓ | ↑ | Normal/↓ | Disseminated intravascular coagulation |
Management
The goal of treatment of easy bruising is to identify and treat the underlying disorder.
Categorize the bruises and other symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild bruises | Moderate to severe bruises and other accompanying symptoms | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initial investigations Complete blood count with platelet count ❑ PT/aPTT ❑ INR ❑ Liver function tests ❑ Thyroid function tests ❑ Renal function tests ❑ Peripheral smear ❑ Bleeding time ❑ Platelet function analyzer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thrombocytopenia Platelet transfusion after ruling out other conditions | Disorders of platelet function | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
von Willebrand disease ❑ Desmopressin releases weibel-palade bodies from endothelial cells ❑ von Willebrand factor concentrate ❑ Tranexamic acid ❑ Estrogen containing oral contraceptive pills for women who are affected ❑ Human-derived medium purity Factor VIII concentrate Glanzmann's thrombasthenia ❑ Avoid aspirin and NSAIDs ❑ Tranexamic acid or Aminocaproic acid ❑ Oral contraceptive pills to decrease menstrual bleeding ❑ Recombinant Factor VIIa Bernard-Soulier syndrome ❑ Platelet transfusion ❑ Tranexamic acid ❑ Avoid aspirin Acquired disorders of platelet function Uremic platelet dysfunction ❑ Erythropoietin can be used for prevention and treatment ❑ Cryoprecipitate can be used in bleeding diathesis ❑ Desmopressin is the agent used most commonly in active bleeding ❑ Estrogen acts by decreasing L-Arginine which in turn decreases Nitric Oxide which sees an increased production in uremia Drugs such as aspirin ❑ Discontinuation of drug ❑ DDAVP for mild bleeding ❑ Platelet transfusion for major bleeding Cardiopulmonary bypass ❑ Heparin ❑ Serine protease inhibitors such as aprotinin ❑ Decreasing platelet adhesiveness with Nitric oxide ❑ Dypyridamole Antiplatelet antibodies ❑ Corticosteroids ❑ Rituximab ❑ Splenectomy ❑ Intravenous immunoglobulin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disorders of secondary hemostasis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemophilia B ❑ Factor IX infusion ❑ Blood or plasma transfusions in severe bleeding ❑ Avoid NSAIDs ❑ Tranexamic acid should be given before any procedure | Hemophilia C ❑ Fresh frozen plasma ❑ Recombinant Factor XI ❑ Cyclokapron is used as a preventative measure and treatment | Disorders of fibrinogen ❑ Afibrinogenemia and hypofibrinogenemia- plasma derived fibrinogen concentrate | |||||||||||||||||||||||||||||||||||||||||||||||||||||
No abnormalities detected on initial screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider other diagnosis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Senile purpura ❑ Topical retinoids may be of some benefit | Infections ❑ Dengue fever * Oral rehydration therapy * Blood transfusion in severe cases ❑ Meningococcal infection * Third generation cephalosporins * Hydration | Aplastic anemia ❑ Bone marrow transplant ❑ Antithymocyte globulin ❑ Chemotherapy in some cases | TTP ❑ Transfusion is contraindicated ❑ Plasmapheresis ❑ Fresh frozen plasma ❑ Cryoprecipitate ❑ Corticosteroids ❑ Rituximab ❑ Caplacizumab ❑ Splenectomy ❑ Immunosupressive agents ITP ❑ Corticosteroids ❑ Splenectomy ❑ Intravenous immunoglobulin ❑ Romiplostim or Etrombopag HUS ❑ Hemodialysis ❑ Corticosteroids ❑ Plasmapheresis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
❑Lupus anticoagulant * LMWH * Warfairn ❑ Antiphospholipid syndrome * Aspirin(preferred in pregnancy) *Warfarin * LMWH ❑ Ehlers-Danlos syndrome * There is no known cure * Physiotherapy and Occupational therapy Vitamin C may help with bruising ❑ Leukemia * Chemotherapy ❑ Plasminogen activator inhibitor-1 deficiency * Tranexamic acid * Aminocaproic acid ❑ Alpha-2 antiplasmin deficiency * Tranexamic acid * Aminocaproic acid ❑ Factor XIII deficiency * Factor XIII concentrate ❑ Liver disease * Eltrombopag * Romiplostim * Platelet transfusions if necessary | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
Dont's
References
- ↑ "Easy Bruising and Bleeding". Am Fam Physician. 93 (4): Online. 2016. PMID 26926825.
- ↑ Sham RL, Francis CW (1994). "Evaluation of mild bleeding disorders and easy bruising". Blood Rev. 8 (2): 98–104. doi:10.1016/s0268-960x(05)80014-1. PMID 7950480.
- ↑ Harrison LB, Nash MJ, Fitzmaurice D, Thachil J (2017). "Investigating easy bruising in an adult". BMJ. 356: j251. doi:10.1136/bmj.j251. PMID 28183694.
- ↑ Bashawri LA, Ahmed MA (2007). "The approach to a patient with a bleeding disorder: for the primary care physician". J Family Community Med. 14 (2): 53–8. PMC 3410146. PMID 23012146.